Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926

Trimodality therapy is an effective potential alternative to radical cystectomy for recurrent high-grade T1 urothelial cancer of the bladder. At 3 years, 88% of the patients remained free of cystectomy.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-09-03
DOI
https://doi.org/10.1200/jco.23.02510
Citations
20
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
11.46

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926

Joseph P. Rodgers, Douglas M. Dahl, William U. Shipley, Felix Yi-Chung Feng et al.
20 citations
Journal of Clinical Oncology
Bladder and Urothelial Cancer Treatments
11.46
article

Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926

Joseph P. Rodgers, Douglas M. Dahl, William U. Shipley, Felix Yi-Chung Feng, A. Jani, M. Dror Michaelson, Theodore Karrison, Jeff M. Michalski, Howard M. Sandler, Chin‐Lee Wu, Jason A. Efstathiou, Daniel Y. Song, Deborah E. Citrin, Richard Hudes, Alan C. Hartford, Fabio Cury, William Parker
article en
20 citations

Abstract

Trimodality therapy is an effective potential alternative to radical cystectomy for recurrent high-grade T1 urothelial cancer of the bladder. At 3 years, 88% of the patients remained free of cystectomy.

Journal of Clinical OncologyVol. 42(34)
Cedars-Sinai Medical Center (US), Dartmouth–Hitchcock Medical Center (US), Saint Agnes Hospital (US), Harvard University (US), Johns Hopkins University (US), Emory University (US), Washington University in St. Louis (US), Thomas Jefferson University Hospital (US), McGill University Health Centre (CA), Massachusetts General Hospital (US), Sidney Kimmel Cancer Center (US), University of California San Francisco Medical Center (US), National Institutes of Health Clinical Center (US), NRG Oncology (US), Sidney Kimmel Comprehensive Cancer Center (US), Winship Cancer Institute
NRG Oncology, National Cancer Institute
Reduced inequalities
Openalex Percentile: Top 1%
Bladder and Urothelial Cancer Treatments
11.46
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.